HUP0102104A2 - Nem-hidratált gabapentin polimorf, előállítására alkalmas eljárás és gyógyszer minőségű gabapentin előállítására való alkalmazása - Google Patents

Nem-hidratált gabapentin polimorf, előállítására alkalmas eljárás és gyógyszer minőségű gabapentin előállítására való alkalmazása

Info

Publication number
HUP0102104A2
HUP0102104A2 HU0102104A HUP0102104A HUP0102104A2 HU P0102104 A2 HUP0102104 A2 HU P0102104A2 HU 0102104 A HU0102104 A HU 0102104A HU P0102104 A HUP0102104 A HU P0102104A HU P0102104 A2 HUP0102104 A2 HU P0102104A2
Authority
HU
Hungary
Prior art keywords
gabapentine
polymorph
hydrated
utilization
production process
Prior art date
Application number
HU0102104A
Other languages
English (en)
Inventor
Jordi Bosch Lladó
Rafael Garcia Cruz
Elías Molins Grau
Miguel María del Carmen Onrubia
Original Assignee
Medichem S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem S.A. filed Critical Medichem S.A.
Publication of HUP0102104A2 publication Critical patent/HUP0102104A2/hu
Publication of HUP0102104A3 publication Critical patent/HUP0102104A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nem hidratált gabapentin polimorfot úgy állítanak elő, hogy gabapentinvizes oldatát permetezve szárítási vagy turbó szárítási eljárássalszárítják, és gyógyszer minőségű gabapentin előállítására használják,oly módon, hogy a polimorfot oldószerekből kristályosítják. Ó
HU0102104A 1998-05-25 1999-05-10 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine HUP0102104A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801078A ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
PCT/ES1999/000127 WO1999061408A1 (es) 1998-05-25 1999-05-10 Polimorfo de gabapentina no hidratada, procedimiento para su obtención y su utilización para la obtención de gabapentina de calidad farmacéutica

Publications (2)

Publication Number Publication Date
HUP0102104A2 true HUP0102104A2 (hu) 2001-11-28
HUP0102104A3 HUP0102104A3 (en) 2002-11-28

Family

ID=8303893

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102104A HUP0102104A3 (en) 1998-05-25 1999-05-10 Non-hydrated gabapentine polymorph, production process and utilization for producing pharmaceutical grade gabapentine

Country Status (9)

Country Link
US (1) US6521787B1 (hu)
EP (1) EP1083164B1 (hu)
AU (1) AU3710699A (hu)
CA (1) CA2333408A1 (hu)
DE (1) DE69912773T2 (hu)
ES (1) ES2137137B1 (hu)
HU (1) HUP0102104A3 (hu)
IL (1) IL139817A (hu)
WO (1) WO1999061408A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169060B1 (en) 1999-04-09 2005-08-31 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
PT1423168E (pt) 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
US6800782B2 (en) 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
ITMI20022071A1 (it) * 2002-10-01 2004-04-02 Erregierre Spa Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
GB2413556B (en) * 2002-11-12 2007-03-14 Tianjin Kinsly Pharmaceutical A new crystal form of adefovir dipivoxil and its composition
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20110224435A1 (en) * 2007-08-07 2011-09-15 Ranbaxy Laboratories Limited Process for preparation of amorphous lopinavir
WO2010091257A1 (en) * 2009-02-06 2010-08-12 Bach Pharma, Inc. Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
JP6283663B2 (ja) 2012-05-17 2018-02-21 ジェネンテック， インコーポレイテッド Ａｋｔを阻害するピリミジニルシクロペンタン化合物の非晶質形態、組成物およびその方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii

Also Published As

Publication number Publication date
EP1083164B1 (en) 2003-11-12
HUP0102104A3 (en) 2002-11-28
IL139817A (en) 2005-11-20
ES2137137B1 (es) 2000-08-16
AU3710699A (en) 1999-12-13
EP1083164A1 (en) 2001-03-14
WO1999061408A1 (es) 1999-12-02
DE69912773D1 (de) 2003-12-18
DE69912773T2 (de) 2004-09-30
US6521787B1 (en) 2003-02-18
CA2333408A1 (en) 1999-12-02
IL139817A0 (en) 2002-02-10
ES2137137A1 (es) 1999-12-01

Similar Documents

Publication Publication Date Title
HUP0102104A2 (hu) Nem-hidratált gabapentin polimorf, előállítására alkalmas eljárás és gyógyszer minőségű gabapentin előállítására való alkalmazása
ATE370109T1 (de) Festphasenherstellung von 18f-markierten aminosäuren
HN2005000548A (es) Procedimiento para producir derivados de amina opticamente activos
ATE249420T1 (de) Herstellung von iodixanol
UY26908A1 (es) Proceso para la fabricación de ácidos n - aril - antranílicos y sus derivados
HUP0202609A2 (hu) Rapamicinszármazékok regioszelektív előállítása
YU94103A (sh) Novi derivati sulfonske kiseline
ES2167541T3 (es) Procedimientos de produccion de alfa-halocetonas, de alfa-halohidrinas y de epoxidos.
HUP0402112A2 (hu) Eljárás kristályos imipenem előállítására
AR021232A1 (es) Procedimiento de preparacion de metionina.
AR030938A1 (es) Proceso de obtencion de los enantiomeros de la cetamina racemica; proceso de obtencion de sales farmaceuticamente aceptables de enantiomeros de la cetamina racemica y utilizacion de las sales farmaceuticamente aceptables obtenidas por el referido proceso
MY112976A (en) Process for purifying valine
HUP0302534A2 (hu) Eljárás mandulasavszármazékok előállítására
BG105426A (bg) Метод за пречистване на амониев сулфат
HUP9901713A2 (hu) Eljárás enantiomer-tiszta 2-azetidinkarbonsav előállítására
HUP0102124A2 (hu) Eljárás 2-acetiltio-3-fenil-propionsav és sói előállítására
ES2119898T3 (es) Procedimiento de produccion de vancomicina.
MX9803887A (es) Produccion de una sal de acido clavulanico.
ATE423091T1 (de) Verfahren zur synthese von l-y- methylenglutaminsäure und analoga
HUP0400825A2 (hu) Eljárás amorf cilastatin nátrium előállítására
HUP0400606A2 (hu) 2-Metil-indol-4-ecetsav és intermedierei és eljárás előállításukra
DE60314904D1 (de) Verfahren zur herstellung von chinoloncarboxylat-derivaten
HUP0300604A2 (hu) Eljárás [6-(4-klór-fenil)-2,2-dimetil-7-fenil-2,3-dihidro-1H-pirrolizin-5-il]-ecetsav és polimorfja előállítására és alkalmazásuk
RS20050980A (en) A process for the preparation of chirally pure n-(trans-4-isopropyl-cyclohexylcarbonil)-d-phenylalanine and crystalline modifications thereof
NO20011031L (no) Fremgangsmåte for fremstilling av N-beskyttede azetidin-2- karboksylsyrer (AzeOHs)

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees